Last 12 months
Inside the activity.
3 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 1 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 1 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 02, 2020 Filed Jul 7, 2020 12:44 UTC |
GOLD DANIEL P PHDDirector · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 680,000 | $0.00 Strike: $3.49 | $0.00 |
DisclosureSEC source: 0000899243-20-018601 · doc4.xml · derivative · entry 2 GOLD DANIEL P PHD · CIK 0001288233 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 680,000 Underlying: Common Stock · 680,000 shares Expires 2030-07-02 F2 · derivative.exercise_date: One-quarter of such options shall vest on July 2, 2021 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 2, 2021. Read SEC document |
| July 02, 2020 Filed Jul 7, 2020 12:44 UTC |
GOLD DANIEL P PHDDirector · Chief Executive Officer
|
GrantCommon Stock | 80,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-018601 · doc4.xml · nonDerivative · entry 1 GOLD DANIEL P PHD · CIK 0001288233 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 441,632 F1 · security: Consists of a grant of restricted stock units, which shall vest on the one-year anniversary of the date of grant. Read SEC document |
| July 02, 2020 Filed Jul 7, 2020 17:40 UTC |
White Christine AnnaDirector
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $3.49 | $0.00 |
DisclosureSEC source: 0000899243-20-018618 · doc4.xml · derivative · entry 1 White Christine Anna · CIK 0001371859 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2030-07-02 F1 · derivative.exercise_date: The options will vest in equal monthly installments over twelve months. Read SEC document |
| July 02, 2020 Filed Jul 7, 2020 17:30 UTC |
Glover NicholasDirector
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $3.49 | $0.00 |
DisclosureSEC source: 0000899243-20-018617 · doc4.xml · derivative · entry 1 Glover Nicholas · CIK 0001578888 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2030-07-02 F1 · derivative.exercise_date: The options will vest in equal monthly installments over twelve months. Read SEC document |
| July 02, 2020 Filed Jul 7, 2020 17:25 UTC |
Reynolds Thomas CDirector
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $3.49 | $0.00 |
DisclosureSEC source: 0000899243-20-018616 · doc4.xml · derivative · entry 1 Reynolds Thomas C · CIK 0001393945 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2030-07-02 F1 · derivative.exercise_date: The options will vest in equal monthly installments over twelve months. Read SEC document |
| July 02, 2020 Filed Jul 7, 2020 17:12 UTC |
Mass Robert D.Chief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 230,000 | $0.00 Strike: $3.49 | $0.00 |
DisclosureSEC source: 0000899243-20-018613 · doc4.xml · derivative · entry 1 Mass Robert D. · CIK 0001522224 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 230,000 Underlying: Common Stock · 230,000 shares Expires 2030-07-02 F1 · derivative.exercise_date: One-quarter of such options shall vest on July 2, 2021 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 2, 2021. Read SEC document |
| July 02, 2020 Filed Jul 7, 2020 17:12 UTC |
HOWSON TAMAR DDirector
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $3.49 | $0.00 |
DisclosureSEC source: 0000899243-20-018612 · doc4.xml · derivative · entry 1 HOWSON TAMAR D · CIK 0001202286 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2030-07-02 F1 · derivative.exercise_date: The options will vest in equal monthly installments over twelve months. Read SEC document |
| July 02, 2020 Filed Jul 7, 2020 17:09 UTC |
Drazba Brian G.Chief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 230,000 | $0.00 Strike: $3.49 | $0.00 |
DisclosureSEC source: 0000899243-20-018611 · doc4.xml · derivative · entry 1 Drazba Brian G. · CIK 0001507369 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 230,000 Underlying: Common Stock · 230,000 shares Expires 2030-07-02 F1 · derivative.exercise_date: One-quarter of such options shall vest on July 2, 2021 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 2, 2021. Read SEC document |
| July 02, 2020 Filed Jul 7, 2020 16:54 UTC |
Baltic Charles V. IIIDirector
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $3.49 | $0.00 |
DisclosureSEC source: 0000899243-20-018606 · doc4.xml · derivative · entry 1 Baltic Charles V. III · CIK 0001533340 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2030-07-02 F1 · derivative.exercise_date: The options will vest in equal monthly installments over twelve months. Read SEC document |
| July 02, 2020 Filed Jul 7, 2020 16:30 UTC |
Cohen CherylDirector
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $3.49 | $0.00 |
DisclosureSEC source: 0000899243-20-018597 · doc4.xml · derivative · entry 1 Cohen Cheryl · CIK 0001529371 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2030-07-02 F1 · derivative.exercise_date: The options will vest in equal monthly installments over twelve months. Read SEC document |
| July 02, 2020 Filed Jul 7, 2020 17:05 UTC |
Clemens KevanDirector
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $3.49 | $0.00 |
DisclosureSEC source: 0000899243-20-018610 · doc4.xml · derivative · entry 1 Clemens Kevan · CIK 0001316737 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2030-07-02 F1 · derivative.exercise_date: The options will vest in equal monthly installments over twelve months. Read SEC document |
| April 10, 2020 Filed Apr 14, 2020 21:17 UTC |
Cohen CherylDirector
|
GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $1.71 | $0.00 |
DisclosureSEC source: 0000899243-20-010723 · doc4.xml · derivative · entry 1 Cohen Cheryl · CIK 0001529371 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2030-04-10 F1 · derivative.exercise_date: 20,000 options will vest in equal monthly installments over thirty-six months from April 10, 2020 and 10,000 options shall vest in equal monthly installments over twelve months from April 10, 2020. Read SEC document |
| December 19, 2019 Filed Dec 20, 2019 17:56 UTC |
DRISCOLL FREDERICK WDirector
|
PurchaseCommon Stock | 62,500 | $1.60 | $100,000.00 |
DisclosureSEC source: 0001209191-19-061473 · doc4.xml · nonDerivative · entry 1 DRISCOLL FREDERICK W · CIK 0001129890 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,500 Read SEC document |
| December 19, 2019 Filed Dec 20, 2019 17:57 UTC |
Reynolds Thomas CDirector
|
PurchaseCommon Stock | 10,000 | $1.60 | $16,000.00 |
DisclosureSEC source: 0001209191-19-061475 · doc4.xml · nonDerivative · entry 1 Reynolds Thomas C · CIK 0001393945 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Read SEC document |
| December 19, 2019 Filed Dec 20, 2019 12:54 UTC |
GOLD DANIEL P PHDDirector · Chief Executive Officer
|
PurchaseCommon Stock | 18,750 | $1.60 | $30,000.00 |
DisclosureSEC source: 0001209191-19-061469 · doc4.xml · nonDerivative · entry 1 GOLD DANIEL P PHD · CIK 0001288233 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 361,632 Read SEC document |
| December 19, 2019 Filed Dec 20, 2019 17:55 UTC |
Drazba Brian G.Chief Financial Officer
|
PurchaseCommon Stock | 12,500 | $1.60 | $20,000.00 |
DisclosureSEC source: 0001209191-19-061471 · doc4.xml · nonDerivative · entry 1 Drazba Brian G. · CIK 0001507369 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,500 Read SEC document |
| September 27, 2019 Filed Oct 1, 2019 12:04 UTC |
GOLD DANIEL P PHDDirector · Chief Executive Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $1.57 | $0.00 |
DisclosureSEC source: 0001209191-19-051197 · doc4.xml · derivative · entry 2 GOLD DANIEL P PHD · CIK 0001288233 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 287,500 Underlying: Common Stock · 20,000 shares Expires 2025-07-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: All of the options are fully vested and currently exercisable. Read SEC document |
| September 27, 2019 Filed Oct 1, 2019 12:04 UTC |
GOLD DANIEL P PHDDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 20,000 | $1.57 | $31,400.00 |
DisclosureSEC source: 0001209191-19-051197 · doc4.xml · nonDerivative · entry 1 GOLD DANIEL P PHD · CIK 0001288233 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 342,882 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 06, 2019 Filed Sep 9, 2019 20:52 UTC |
White Christine AnnaDirector
|
PurchaseCommon Stock | 15,000 | $1.74 | $26,074.50 |
DisclosureSEC source: 0001209191-19-048913 · doc4.xml · nonDerivative · entry 1 White Christine Anna · CIK 0001371859 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 F1 · kind: The shares purchased by the reporting person are held through an Individual Retirement Account. F2 · price: The weighted average purchase price for the transaction reported was $1.7383, and the range of prices was between $1.725 and $1.74. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided. Read SEC document |
| July 01, 2019 Filed Jul 3, 2019 19:32 UTC |
DRISCOLL FREDERICK WDirector
|
GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $2.52 | $0.00 |
DisclosureSEC source: 0001209191-19-040977 · doc4.xml · derivative · entry 1 DRISCOLL FREDERICK W · CIK 0001129890 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2029-07-01 F1 · derivative.exercise_date: The options will vest in equal monthly installments over twelve months. Read SEC document |
| July 01, 2019 Filed Jul 3, 2019 15:36 UTC |
Urso David MChief Operating Officer & GC
|
GrantStock Option (Right to Buy) · Derivative | 350,000 | $0.00 Strike: $2.52 | $0.00 |
DisclosureSEC source: 0001209191-19-040989 · doc4.xml · derivative · entry 1 Urso David M · CIK 0001604256 · Chief Operating Officer & GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 350,000 Underlying: Common Stock · 350,000 shares Expires 2029-07-01 F1 · derivative.exercise_date: One-quarter of such Options shall vest on July 1, 2020 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 1, 2020. Read SEC document |
| July 01, 2019 Filed Jul 3, 2019 15:35 UTC |
GOLD DANIEL P PHDDirector · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 680,000 | $0.00 Strike: $2.52 | $0.00 |
DisclosureSEC source: 0001209191-19-040985 · doc4.xml · derivative · entry 1 GOLD DANIEL P PHD · CIK 0001288233 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 680,000 Underlying: Common Stock · 680,000 shares Expires 2029-07-01 F1 · derivative.exercise_date: One-quarter of such Options shall vest on July 1, 2020 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 1, 2020. Read SEC document |
| July 01, 2019 Filed Jul 3, 2019 19:34 UTC |
White Christine AnnaDirector
|
GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $2.52 | $0.00 |
DisclosureSEC source: 0001209191-19-040983 · doc4.xml · derivative · entry 1 White Christine Anna · CIK 0001371859 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2029-07-01 F1 · derivative.exercise_date: The options will vest in equal monthly installments over twelve months. Read SEC document |
| July 01, 2019 Filed Jul 3, 2019 19:31 UTC |
Baltic Charles V. IIIDirector
|
GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $2.52 | $0.00 |
DisclosureSEC source: 0001209191-19-040975 · doc4.xml · derivative · entry 1 Baltic Charles V. III · CIK 0001533340 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2029-07-01 F1 · derivative.exercise_date: The options will vest in equal monthly installments over twelve months. Read SEC document |
| July 01, 2019 Filed Jul 3, 2019 19:36 UTC |
Mass Robert D.Chief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 230,000 | $0.00 Strike: $2.52 | $0.00 |
DisclosureSEC source: 0001209191-19-040987 · doc4.xml · derivative · entry 1 Mass Robert D. · CIK 0001522224 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 230,000 Underlying: Common Stock · 230,000 shares Expires 2029-07-01 F1 · derivative.exercise_date: One-quarter of such Options shall vest on July 1, 2020 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 1, 2020. Read SEC document |
| July 01, 2019 Filed Jul 3, 2019 19:35 UTC |
Drazba Brian G.Chief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 230,000 | $0.00 Strike: $2.52 | $0.00 |
DisclosureSEC source: 0001209191-19-040984 · doc4.xml · derivative · entry 1 Drazba Brian G. · CIK 0001507369 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 230,000 Underlying: Common Stock · 230,000 shares Expires 2029-07-01 F1 · derivative.exercise_date: One-quarter of such Options shall vest on July 1, 2020 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 1, 2020. Read SEC document |
| July 01, 2019 Filed Jul 3, 2019 19:33 UTC |
Rueckert William DodgeDirector
|
GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $2.52 | $0.00 |
DisclosureSEC source: 0001209191-19-040981 · doc4.xml · derivative · entry 1 Rueckert William Dodge · CIK 0001380016 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2029-07-01 F1 · derivative.exercise_date: The options will vest in equal monthly installments over twelve months. Read SEC document |
| July 01, 2019 Filed Jul 3, 2019 19:33 UTC |
Reynolds Thomas CDirector
|
GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $2.52 | $0.00 |
DisclosureSEC source: 0001209191-19-040980 · doc4.xml · derivative · entry 1 Reynolds Thomas C · CIK 0001393945 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2029-07-01 F1 · derivative.exercise_date: The options will vest in equal monthly installments over twelve months. Read SEC document |
| July 01, 2019 Filed Jul 3, 2019 19:32 UTC |
Glover NicholasDirector
|
GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $2.52 | $0.00 |
DisclosureSEC source: 0001209191-19-040979 · doc4.xml · derivative · entry 1 Glover Nicholas · CIK 0001578888 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2029-07-01 F1 · derivative.exercise_date: The options will vest in equal monthly installments over twelve months. Read SEC document |
| July 01, 2019 Filed Jul 3, 2019 19:31 UTC |
Clemens KevanDirector
|
GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $2.52 | $0.00 |
DisclosureSEC source: 0001209191-19-040976 · doc4.xml · derivative · entry 1 Clemens Kevan · CIK 0001316737 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2029-07-01 F1 · derivative.exercise_date: The options will vest in equal monthly installments over twelve months. Read SEC document |
| July 01, 2019 Filed Jul 3, 2019 19:30 UTC |
HOWSON TAMAR DDirector
|
GrantStock Option (Right to Buy) · Derivative | 60,000 | $0.00 Strike: $2.52 | $0.00 |
DisclosureSEC source: 0001209191-19-040974 · doc4.xml · derivative · entry 1 HOWSON TAMAR D · CIK 0001202286 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2029-07-01 F1 · derivative.exercise_date: 20,000 options will vest in equal monthly installments over thirty-six months, and 40,000 of the options will vest in equal monthly installments over twelve months. Read SEC document |
| August 07, 2018 Filed Aug 8, 2018 18:01 UTC |
Urso David MChief Operating Officer & GC
|
SaleCommon Stock | 9,500 | $3.58 | $34,044.20 |
DisclosureSEC source: 0001209191-18-045899 · doc4.xml · nonDerivative · entry 2 Urso David M · CIK 0001604256 · Chief Operating Officer & GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,106 F2 · shares: Represents the number of shares sold to satisfy tax withholding obligations that arose in connection with the delivery of shares underlying restricted stock units that vested on August 5, 2018. F3 · price: The range of sales prices was $3.5825 to $3.60. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price. Read SEC document |
| August 06, 2018 Filed Aug 8, 2018 18:01 UTC |
Urso David MChief Operating Officer & GC
|
Tax withholdingCommon Stock | 17,764 | $3.75 | $66,615.00 |
DisclosureSEC source: 0001209191-18-045899 · doc4.xml · nonDerivative · entry 1 Urso David M · CIK 0001604256 · Chief Operating Officer & GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,606 F1 · shares: Represents the number of shares withheld by and surrendered to the Issuer on August 6, 2018, to satisfy tax withholding obligations that arose in connection with the delivery of shares underlying restricted stock units that vested on August 5, 2018. Read SEC document |
| August 06, 2018 Filed Aug 8, 2018 17:59 UTC |
GOLD DANIEL P PHDDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 54,093 | $3.75 | $202,848.75 |
DisclosureSEC source: 0001209191-18-045895 · doc4.xml · nonDerivative · entry 1 GOLD DANIEL P PHD · CIK 0001288233 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 319,727 F1 · shares: Represents the number of shares withheld by and surrendered to the Issuer on August 6, 2018, to satisfy tax withholding obligations that arose in connection with the delivery of shares underlying restricted stock units that vested on August 5, 2018. Read SEC document |
| August 06, 2018 Filed Aug 8, 2018 22:00 UTC |
Mass Robert D.Chief Medical Officer
|
Tax withholdingCommon Stock | 17,709 | $3.75 | $66,408.75 |
DisclosureSEC source: 0001209191-18-045897 · doc4.xml · nonDerivative · entry 1 Mass Robert D. · CIK 0001522224 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,661 F1 · shares: Represents the number of shares withheld by and surrendered to the Issuer on August 6, 2018, to satisfy tax withholding obligations that arose in connection with the delivery of shares underlying restricted stock units that vested on August 5, 2018. Read SEC document |
| August 06, 2018 Filed Sep 6, 2018 20:20 UTC Amendment |
GOLD DANIEL P PHDDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 50,938 | $3.75 | $191,017.50 |
DisclosureSEC source: 0001209191-18-049972 · doc4a.xml · nonDerivative · entry 1 GOLD DANIEL P PHD · CIK 0001288233 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 322,882 F1 · shares: Represents the number of shares withheld by and surrendered to the Issuer on August 6, 2018, to satisfy tax withholding obligations that arose in connection with the delivery of shares underlying restricted stock units that vested on August 5, 2018. The number of shares withheld by and surrendered to the Issuer was incorrectly reported as 54,093 in the original filing of the Form 4 to which this amendment relates. Such number of shares withheld was overstated by 3,155 shares. F2 · balance_after: The number of shares beneficially owned was incorrectly understated by 3,155 shares in the original filing of the Form 4 to which this amendment relates as a result of the incorrect reporting of the number of shares withheld described in Note 1 above. Read SEC document |
| July 12, 2018 Filed Jul 16, 2018 21:26 UTC |
DRISCOLL FREDERICK WDirector
|
GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $4.28 | $0.00 |
DisclosureSEC source: 0001209191-18-042667 · doc4.xml · derivative · entry 1 DRISCOLL FREDERICK W · CIK 0001129890 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2028-07-12 F1 · derivative.exercise_date: The options will vest in equal monthly installments over twelve months. Read SEC document |
| July 12, 2018 Filed Jul 16, 2018 17:35 UTC |
Urso David MChief Operating Officer & GC
|
GrantStock Option (Right to Buy) · Derivative | 220,000 | $0.00 Strike: $4.28 | $0.00 |
DisclosureSEC source: 0001209191-18-042688 · doc4.xml · derivative · entry 1 Urso David M · CIK 0001604256 · Chief Operating Officer & GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 220,000 Underlying: Common Stock · 220,000 shares Expires 2028-07-12 F1 · derivative.exercise_date: One-quarter of such Options shall vest on July 12, 2019 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 12, 2019. Read SEC document |
| July 12, 2018 Filed Jul 16, 2018 17:33 UTC |
GOLD DANIEL P PHDDirector · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 300,000 | $0.00 Strike: $4.28 | $0.00 |
DisclosureSEC source: 0001209191-18-042683 · doc4.xml · derivative · entry 1 GOLD DANIEL P PHD · CIK 0001288233 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2028-07-12 F1 · derivative.exercise_date: One-quarter of such Options shall vest on July 12, 2019 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 12, 2019. Read SEC document |
| July 12, 2018 Filed Jul 16, 2018 21:34 UTC |
Mass Robert D.Chief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 130,000 | $0.00 Strike: $4.28 | $0.00 |
DisclosureSEC source: 0001209191-18-042686 · doc4.xml · derivative · entry 1 Mass Robert D. · CIK 0001522224 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,000 Underlying: Common Stock · 130,000 shares Expires 2028-07-12 F1 · derivative.exercise_date: One-quarter of such Options shall vest on July 12, 2019 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 12, 2019. Read SEC document |
| July 12, 2018 Filed Jul 16, 2018 21:30 UTC |
White Christine AnnaDirector
|
GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $4.28 | $0.00 |
DisclosureSEC source: 0001209191-18-042678 · doc4.xml · derivative · entry 1 White Christine Anna · CIK 0001371859 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2028-07-12 F1 · derivative.exercise_date: The options will vest in equal monthly installments over twelve months. Read SEC document |
| July 12, 2018 Filed Jul 16, 2018 21:32 UTC |
Drazba Brian G.Chief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $4.28 | $0.00 |
DisclosureSEC source: 0001209191-18-042681 · doc4.xml · derivative · entry 1 Drazba Brian G. · CIK 0001507369 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2028-07-12 F1 · derivative.exercise_date: One-quarter of such Options shall vest on July 12, 2019 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 12, 2019. Read SEC document |
| July 12, 2018 Filed Jul 16, 2018 21:29 UTC |
Rueckert William DodgeDirector
|
GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $4.28 | $0.00 |
DisclosureSEC source: 0001209191-18-042676 · doc4.xml · derivative · entry 1 Rueckert William Dodge · CIK 0001380016 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2028-07-12 F1 · derivative.exercise_date: The options will vest in equal monthly installments over twelve months. Read SEC document |
| July 12, 2018 Filed Jul 16, 2018 21:28 UTC |
Reynolds Thomas CDirector
|
GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $4.28 | $0.00 |
DisclosureSEC source: 0001209191-18-042673 · doc4.xml · derivative · entry 1 Reynolds Thomas C · CIK 0001393945 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2028-07-12 F1 · derivative.exercise_date: The options will vest in equal monthly installments over twelve months. Read SEC document |
| July 12, 2018 Filed Jul 16, 2018 21:25 UTC |
Clemens KevanDirector
|
GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $4.28 | $0.00 |
DisclosureSEC source: 0001209191-18-042665 · doc4.xml · derivative · entry 1 Clemens Kevan · CIK 0001316737 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2028-07-12 F1 · derivative.exercise_date: The options will vest in equal monthly installments over twelve months. Read SEC document |
| July 12, 2018 Filed Jul 16, 2018 21:27 UTC |
Glover NicholasDirector
|
GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $4.28 | $0.00 |
DisclosureSEC source: 0001209191-18-042670 · doc4.xml · derivative · entry 1 Glover Nicholas · CIK 0001578888 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2028-07-12 F1 · derivative.exercise_date: The options will vest in equal monthly installments over twelve months. Read SEC document |
| July 12, 2018 Filed Jul 16, 2018 21:24 UTC |
Baltic Charles V. IIIDirector
|
GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $4.28 | $0.00 |
DisclosureSEC source: 0001209191-18-042663 · doc4.xml · derivative · entry 1 Baltic Charles V. III · CIK 0001533340 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2028-07-12 F1 · derivative.exercise_date: The options will vest in equal monthly installments over twelve months. Read SEC document |
| June 22, 2018 Filed Jun 26, 2018 14:27 UTC |
Urso David MSr. V.P. and General Counsel
|
GrantStock Option (Right to Buy) · Derivative | 130,000 | $0.00 Strike: $4.33 | $0.00 |
DisclosureSEC source: 0000899243-18-018105 · doc4.xml · derivative · entry 1 Urso David M · CIK 0001604256 · Sr. V.P. and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,000 Underlying: Common Stock · 130,000 shares Expires 2028-06-22 F1 · derivative.exercise_date: One-quarter of such Options shall vest on June 22, 2019 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on June 22, 2019. Read SEC document |
| June 22, 2018 Filed Jun 26, 2018 14:27 UTC |
GOLD DANIEL P PHDDirector · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 380,000 | $0.00 Strike: $4.33 | $0.00 |
DisclosureSEC source: 0000899243-18-018107 · doc4.xml · derivative · entry 1 GOLD DANIEL P PHD · CIK 0001288233 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 380,000 Underlying: Common Stock · 380,000 shares Expires 2028-06-22 F1 · derivative.exercise_date: One-quarter of such Options shall vest on June 22, 2019 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on June 22, 2019. Read SEC document |
| June 22, 2018 Filed Jun 26, 2018 18:33 UTC |
Drazba Brian G.Chief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 130,000 | $0.00 Strike: $4.33 | $0.00 |
DisclosureSEC source: 0000899243-18-018110 · doc4.xml · derivative · entry 1 Drazba Brian G. · CIK 0001507369 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,000 Underlying: Common Stock · 130,000 shares Expires 2028-06-22 F1 · derivative.exercise_date: One-quarter of such Options shall vest on June 22, 2019 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on June 22, 2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.